查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566940

生物相容性塗料市場：按類型、材料和最終用戶分類：2024-2033 年全球機會分析和產業預測

Biocompatible Coating Market By Type (Antimicrobial, Hydrophilic, Others) , By Material (Polymer, Ceramic, Metal, Others) By End User (Healthcare, Medical Device, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年生物相容性塗料市場價值為134億美元，預計2024年至2033年複合年成長率為12%，到2033年達到414億美元。

生物相容性塗層是應用於醫療設備、植入和其他醫療保健相關材料的生物材料，以確保與人體生物環境的兼容性。這些塗層旨在促進設備與周圍組織之間的和諧相互作用，從而最大限度地減少發炎和排斥等副作用。透過賦予耐腐蝕性、耐磨性和生物活性等特性來提高醫療植入的性能和壽命，對於推進醫療技術和改善患者治療效果至關重要。

由於老年人口的迅速成長和慢性病患病率的上升，對整形外科、牙科和心血管設備等醫療植入的需求不斷成長，推動了全球生物相容性塗料市場的成長，這些醫療植入需要生物相容性塗料來確保安全和安全。此外，對降低感染疾病和植入排斥等併發症風險的日益重視正在推動生物相容性塗層的採用，以提高醫療設備的安全性和相容性。此外，製藥業的擴張和藥物傳輸系統需求的激增需要生物相容性塗層來確保活性藥物成分的控制釋放和穩定性，從而促進市場成長。此外，開發具有抗菌特性的生物相容性塗層以降低與醫療植入和醫療設備相關的感染疾病風險的趨勢也在顯著推動市場成長。這些含有銀離子和其他抗菌劑的塗層對於預防術後併發症至關重要。然而，生物相容性塗料的研發高成本，尤其是那些採用奈米技術和生物活性物質等先進材料的塗料，阻礙了市場的成長。這是由於開發兼俱生物相容性和耐用性的塗層存在技術困難。確保穩定的膜厚度、防止隨時間劣化以及實現所需的功能特性等問題可能會限制某些塗層的擴充性和適用性。同時，醫療設備設計和製造的技術創新，例如微創手術的發展，正在推動對先進生物相容性塗層的需求，以提高這些設備的性能和耐用性。預計這些新興市場的開拓將為預測期內的市場成長提供有利可圖的機會。

全球生物相容性塗料產業按類型、材料、最終用戶和地區細分。按類型分類，市場分為抗菌、親水等。依材質分為聚合物、陶瓷、金屬等。按最終使用者分為醫療保健、醫療設備和其他。按地區分類，對北美、歐洲、亞太地區和拉丁美洲地區市場進行了分析。

主要發現

按類型分類，抗菌塗料領域預計將在 2024 年至 2033 年期間主導全球市場。

從材料來看，聚合物預計將在預測期內成為主要部分。

從最終用戶來看，醫療設備產業預計在未來幾年將顯著成長。

按地區分類，就 2023 年以收益為準，北美佔據最大市場佔有率，預計在預測期內也將主導市場。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 根據客戶興趣加入公司簡介
  • 公司簡介的擴充列表
  • 歷史市場資料

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章生物相容性塗料市場：依類型

  • 市場概況
  • 抗菌的
  • 親水性的
  • 其他

第5章生物相容性塗料市場：依材料分類

  • 市場概況
  • 聚合物
  • 陶瓷製品
  • 金屬
  • 其他

第6章生物相容性塗料市場：依最終用戶分類

  • 市場概況
  • 衛生保健
  • 醫療設備
  • 其他

第7章生物相容性塗料市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國生物相容性塗料市場
    • 加拿大生物相容性塗料市場
    • 墨西哥生物相容性塗料市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國生物相容性塗料市場
    • 德國生物相容性塗料市場
    • 義大利生物相容性塗料市場
    • 西班牙生物相容性塗料市場
    • 英國生物相容性塗料市場
    • 其他歐洲國家生物相容性塗料市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國生物相容性塗料市場
    • 日本生物相容性塗料市場
    • 印度生物相容性塗料市場
    • 韓國生物相容性塗料市場
    • 澳洲生物相容性塗料市場
    • 其他亞太生物相容性塗料市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西生物相容性塗料市場
    • 南非生物相容性塗料市場
    • 沙烏地阿拉伯生物相容性塗料市場
    • 其他拉丁美洲/中東/非洲生物相容性塗料市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • DSM Biomedical BV
  • Surmodics, Inc.
  • BASF SE
  • Covalon Technologies Ltd.
  • Harland Medical Systems, LLC
  • Biocoat, Inc.
  • BioInteractions Ltd.
  • AST Products, Inc.
  • PPG Industries
  • Precision Coating Company, Inc.
簡介目錄
Product Code: A323973

The biocompatible coating market was valued at $13.4 billion in 2023, and is projected to reach $41.4 billion by 2033, growing at a CAGR of 12% from 2024 to 2033.

Biocompatible coatings are biomaterials that are applied to medical devices, implants, and other healthcare-related materials to ensure they are compatible with the biological environment of the human body. These coatings are designed to minimize adverse reactions, such as inflammation or rejection, by promoting a harmonious interaction between the device and surrounding tissues. They enhance the performance and longevity of medical implants by imparting properties like anti-corrosion, anti-wear, and bioactivity, making them essential in advancing medical technology and improving patient outcomes.

The growth of the global biocompatible coating market is driven by surge in geriatric population and rise in prevalence of chronic diseases that are leading to increased need for medical implants, such as orthopedic, dental, and cardiovascular devices, which require biocompatible coatings for safe and effective integration with the body. According to the 2022 American Joint Replacement Registry (AJRR) annual report, approximately 2.8 million hip and knee procedures were carried out in the U.S. Moreover, rise in emphasis on reducing the risk of complications, such as infections and implant rejection, is driving the adoption of biocompatible coatings that improve the safety and compatibility of medical devices. Furthermore, the expansion of the pharmaceutical sector and surge in demand for drug delivery systems, which require biocompatible coatings to ensure controlled release and stability of active pharmaceutical ingredients, contribute toward the market growth. Moreover, the growing trend toward developing biocompatible coatings with antimicrobial properties to reduce the risk of infections associated with medical implants and devices is significantly fostering the market growth. These coatings, incorporating silver ions or other antimicrobial agents, are crucial in preventing postoperative complications. However, high cost associated with R&D of biocompatible coatings, especially those incorporating advanced materials like nanotechnology or bioactive substances, hampers the market growth. This is attributed to the fact that developing coatings that are both biocompatible and durable is technically challenging. Issues such as ensuring consistent coating thickness, preventing degradation over time, and achieving the desired functional properties can limit the scalability and applicability of certain coatings. On the contrary, innovations in medical device design and manufacturing, including the development of minimally invasive procedures, are driving the demand for advanced biocompatible coatings that enhance the performance and durability of these devices. Such developments are expected to offer lucrative opportunities for the market growth during the forecast period.

The global biocompatible coating industry is segmented into type, material, end user, and region. On the basis of type, the market is fragmented into antimicrobial, hydrophilic, and others. Depending on material, it is divided into polymer, ceramic, metal, and others. As per end user, it is segregated into healthcare, medical device, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the antimicrobial coatings segment is expected to dominate the global market from 2024 to 2033.

Depending on material, polymers is anticipated to emerge as a leading segment during the forecast period.

As per end user, the medical device segment is projected to exhibit notable growth in the coming years.

Region wise, North America held the largest market share in terms of revenue in 2023, and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global biocompatible coating market include DSM Biomedical B.V., Surmodics, Inc., BASF SE, Covalon Technologies Ltd., Harland Medical Systems, LLC, Biocoat, Inc., BioInteractions Ltd., AST Products, Inc., PPG Industries, and Precision Coating Company, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Antimicrobial
  • Hydrophilic
  • Others

By Material

  • Polymer
  • Ceramic
  • Metal
  • Others

By End User

  • Healthcare
  • Medical Device
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • DSM Biomedical B.V.
    • Surmodics, Inc.
    • BASF SE
    • Covalon Technologies Ltd.
    • Harland Medical Systems, LLC
    • Biocoat, Inc.
    • BioInteractions Ltd.
    • AST Products, Inc.
    • PPG Industries
    • Precision Coating Company, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIOCOMPATIBLE COATING MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Antimicrobial
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Hydrophilic
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BIOCOMPATIBLE COATING MARKET, BY MATERIAL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Material
  • 5.2. Polymer
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Ceramic
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Metal
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: BIOCOMPATIBLE COATING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Healthcare
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Medical Device
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: BIOCOMPATIBLE COATING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Material
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Biocompatible Coating Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Material
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Biocompatible Coating Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Material
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Biocompatible Coating Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Material
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Material
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Biocompatible Coating Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Material
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Biocompatible Coating Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Material
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Biocompatible Coating Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Material
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Biocompatible Coating Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Material
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Biocompatible Coating Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Material
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Biocompatible Coating Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Material
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Material
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Biocompatible Coating Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Material
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Biocompatible Coating Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Material
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Biocompatible Coating Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Material
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Biocompatible Coating Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Material
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Biocompatible Coating Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Material
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Biocompatible Coating Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Material
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Material
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Biocompatible Coating Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Material
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Biocompatible Coating Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Material
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Biocompatible Coating Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Material
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Biocompatible Coating Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Material
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. DSM Biomedical B.V.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Surmodics, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. BASF SE
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Covalon Technologies Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Harland Medical Systems, LLC
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Biocoat, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. BioInteractions Ltd.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. AST Products, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. PPG Industries
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Precision Coating Company, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments